What is the price target for PMN stock?
8 analysts have analysed PMN and the average price target is 83 USD. This implies a price increase of 357.31% is expected in the next year compared to the current price of 18.15.
NASDAQ:PMN • CA74346M5054
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PROMIS NEUROSCIENCES INC (PMN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-06 | Guggenheim | Maintains | Buy -> Buy |
| 2025-12-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-18 | Guggenheim | Maintains | Buy -> Buy |
| 2025-07-14 | HC Wainwright & Co. | Initiate | Buy |
| 2025-05-12 | Maxim Group | Initiate | Buy |
| 2025-04-01 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-02-26 | Guggenheim | Reiterate | Buy -> Buy |
| 2023-10-03 | BTIG | Initiate | Buy |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 20K | -100.00% | 10K | 505 -100.00% | 10.1M | N/A | N/A | 36.344M | 148.44M 308.43% | 282.15M 90.08% | |||||||
| EBITDA YoY % growth | -1.54M | -2.59M -68.18% | -4.62M -78.38% | N/A -69.48% | N/A 28.86% | N/A 24.42% | N/A -95.72% | -16.968M -183.50% | -21.21M 39.03% | -26.765M -87.94% | -22.624M 15.47% | -23.23M -2.68% | -11.211M 51.74% | 29.763M 365.48% | 141.34M 374.88% | 274.45M 94.18% | |
| EBIT YoY % growth | -1.55M | -2.6M -67.74% | -4.63M -78.08% | -9.561M -69.33% | -10.605M 28.83% | N/A 24.37% | N/A -96.45% | -17.271M -182.03% | -13.641M 39.00% | -19.421M -36.16% | -35.996M -85.35% | -40.987M -13.86% | -58.672M -43.15% | 29.464M 150.22% | 141.04M 378.69% | 274.15M 94.38% | |
| Operating Margin | -7,750.00% | N/A | -46,300.00% | -1,893,300.00% | -105.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 81.07% | 95.01% | 97.16% | |
| EPS YoY % growth | N/A | N/A | N/A | -2.67 -32.01% | 0.30 | N/A | N/A | -2.08 | -26.77 -1,186.41% | -1.39 108.41% | -23.18 -1,130.20% | -9.35 59.65% | -5.46 41.63% | N/A | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -4.93 -1,870.17% | -1.93 63.19% | -4.67 35.57% | -4.29 28.46% | -4.55 7.72% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.527M -75.38% | -11.023M -47.75% | -10.357M -1.69% | -11.219M 4.52% | -11.651M -10.68% |
All data in USD
8 analysts have analysed PMN and the average price target is 83 USD. This implies a price increase of 357.31% is expected in the next year compared to the current price of 18.15.
PROMIS NEUROSCIENCES INC (PMN) will report earnings on 2026-03-30, after the market close.
The consensus EPS estimate for the next earnings of PROMIS NEUROSCIENCES INC (PMN) is -4.93 USD and the consensus revenue estimate is 0 USD.
The consensus rating for PROMIS NEUROSCIENCES INC (PMN) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.